The primary aim of acquisition is to expand into high-entry barrier and super-specialty segments, particularly in women's health and fertility, where BSV has a strong presence
Read More
The Government of India’s Amrit Kaal blueprint -Vision Pharma 2047 – which envisages India as ‘Vishwaguru’ (global leader) in innovation & research underscores the Government's commitment to nurture an innovation-driven ecosystem
Read More
To develop sustainable strategies, the FY25 has witnessed a 12.9 per cent increase from the revised estimate of Rs.80,517.62 crore
Read More
This move follows a strategic agreement with HCL Tech, aimed at enhancing Olympus' innovation activities worldwide
Read More
